CureVac N.V. announced unaudited consolidated financial results for the second quarter and first half year ended June 30, 2021. For the quarter, revenue was €34.5 million against €22.4 million for the same period of last year. Operating loss was €3.2 million against €147.8 million for the same period of last year. Financial loss was €8.8 million against €4.4 million for the same period of last year. For the six months, revenue was €37.7 million against €32.4 million for the same period of last year. Operating Result was €26.4 million against €263.7 million for the same period of last year. Financial loss was €9.5 million against €0.7 million for the same period of last year.